China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research report sent to investors on Sunday. The firm issued a hold rating on the stock.

China Pharma Stock Performance

NYSE:CPHI opened at $0.25 on Friday. China Pharma has a twelve month low of $0.13 and a twelve month high of $0.41. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22. The stock’s 50 day moving average price is $0.23 and its two-hundred day moving average price is $0.22.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.